Zeng et al. introduced a case of lung adenocarcinoma with rare KIF5B-ALK (intron 20 of KIF5B is connected to intron 20 of ALK) and obtained PFS for 11 months after treatment with crizotinib [78]. This evidence concerns the gene ALK and lung adenocarcinoma.